Back to Search
DR. JOSHUA MICHAEL DOORN M.D.
M.D.
Family Medicine Physician
NPI: 1801244405IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
0300(SD)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
0300(SD)
Education
SANFORD SCHOOL OF MEDICINE OF UNIVERSITY OF SOUTH DAKOTA
Class of 2016
Research & Publications (20)
Developmental emergence of power-law wake behavior depends upon the functional integrity of the locus coeruleus.
PMID 19639755·Sleep·2009
7-preclinical
Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.
PMID 19537779·Chem Res Toxicol·2009
7-preclinical
Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells.
PMID 19393338·Biochim Biophys Acta·2009
8-other
Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.
PMID 19388687·Chem Res Toxicol·2009
7-preclinical
Consumer assessment of safety and date labeling statements on ready-to-eat meat and poultry products designed to minimize risk of listeriosis.
PMID 18236665·J Food Prot·2008
8-other
In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal.
PMID 19548352·Chem Res Toxicol·2008
7-preclinical
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo.
PMID 18490653·Proc Natl Acad Sci U S A·2008
8-other
4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction.
PMID 17164404·Mol Pharmacol·2007
7-preclinical
Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
PMID 16956664·Neurotoxicology·2007
7-preclinical
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate.
PMID 17887726·Chem Res Toxicol·2007
7-preclinical
Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization.
PMID 17630713·Chem Res Toxicol·2007
7-preclinical
Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal.
PMID 16411662·Chem Res Toxicol·2006
8-other
Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.
PMID 16097806·Chem Res Toxicol·2005
7-preclinical
Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease.
PMID 15951401·J Pharmacol Exp Ther·2005
7-preclinical
Reactions of 4-hydroxynonenal with proteins and cellular targets.
PMID 15336309·Free Radic Biol Med·2004
6-review
Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal.
PMID 15540944·Chem Res Toxicol·2004
7-preclinical
Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal.
PMID 15476404·Biochemistry·2004
7-preclinical
4-Hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase.
PMID 15454282·Free Radic Biol Med·2004
7-preclinical
Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal.
PMID 12604193·Chem Biol Interact·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1115 E 20TH ST
SIOUX FALLS, SD 57105 - Phone
- (605) 339-1783
Quick Facts
- NPI
- 1801244405
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile